Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Meredith

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human SubjectsJeremy H Toyn, Kenneth M Boy, Joseph Raybon, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Pharmacodynamics of selective inhibition of γ-secretase by avagacestatCharles F Albright, Randy C Dockens, Jere E Meredith, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.
International Journal of Alzheimer'S Disease|August 7, 2014
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780Jeremy H Toyn, Lorin A Thompson, Kimberley A Lentz, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human SubjectsJeremy H Toyn, Kenneth M Boy, Joseph Raybon, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Pharmacodynamics of selective inhibition of γ-secretase by avagacestatCharles F Albright, Randy C Dockens, Jere E Meredith, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.
International Journal of Alzheimer'S Disease|August 7, 2014
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780Jeremy H Toyn, Lorin A Thompson, Kimberley A Lentz, et al.
Pageof 19